Inhibitory mechanisms of activated matrix metalloproteinase-9 on platelet activation

European Journal of Pharmacology

Volumn 537, Issue 1-3, 2006, Pages 52-58

  Lee, Ye Ming ^a   Lee, Jie Jen ^a   Shen, Ming Yi ^b   Hsiao, George ^b   Sheu, Joen Rong ^b  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Hydroxyl radical; Matrix metalloproteinase 9; Membrane fluidity; Na+ H+ exchanger; Platelet aggregation

Indexed keywords

1,6 DIPHENYL 1,3,5 HEXATRIENE; COLLAGEN; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; FLUORESCEIN ISOTHIOCYANATE; GELATINASE B; HYDROXYL RADICAL; SNAKE VENOM; SODIUM PROTON EXCHANGE PROTEIN; TRIFLAVIN;

ARTICLE; CALCIUM TRANSPORT; CELL SUSPENSION; CONTROLLED STUDY; DRUG BINDING; DRUG MECHANISM; ELECTRON SPIN RESONANCE; ENZYME ACTIVATION; ENZYME INHIBITION; FLUORESCENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE;

BLOOD PLATELETS; CELLS, CULTURED; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROXYL RADICAL; L-LACTATE DEHYDROGENASE; MATRIX METALLOPROTEINASE 9; MEMBRANE FLUIDITY; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;

EID: 33646164416     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.03.031     Document Type: Article

References (25)

1. + antiporter inhibitors. J. Med. Chem. 41 (1998) 3736-3747
2. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 7 (1995) 728-735
3. + antiporter 3 (NHE3) requires PDZ domain adapter NHERF2, a broad specificity protein kinase G-anchoring protein. J. Biol. Chem. 280 (2005) 16642-16650
4. Dollery C.M., McEwan J.R., and Henney A.M. Matrix metalloproteinases and cardiovascular diseases. Circ. Res. 77 (1995) 863-868
5. Fernandez-Patron C., Martinez-Cuesta M.A., Salas E., Sawicki G., Wozniak M., Radomski M.W., and Davidge S.T. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb. Haemost. 82 (1999) 1730-1735
6. Iuliano L., Pedersen J.Z., Pratico D., Rotilio G., and Violi F. Role of hydroxyl radicals in the activation of human platelets. Eur. J. Biochem. 221 (1994) 695-704
7. 2+. J. Clin. Invest. 89 (1992) 1121-1127
8. Kitagawa S., Shinohara T., and Kametani F. Effects of alcohols on ADP-induced aggregation and membrane fluidity of gel-filtered bovine blood platelets. J. Membr. Biol. 79 (1984) 97-102
9. Kobayashi T., Yamada J., Setaka M., and Kwan T. Effects of chlorpromazine and other calmodulin antagonists on phosphatidylcholine-induced vesiculation of platelet plasma membranes. Biochim. Biophys. Acta 855 (1986) 58-62
10. Leo R., Ghisell I.A., Iuliano L., and Violi F. Detection of hydroxyl radicals by the salicylate bis-hydroxylation during arachidonic acid-dependent platelet activation. Thromb. Haemost. 73 (1995) A347
11. Lijnen H.R. Plasmin and matrix metalloproteinases in vascular remodeling. Thromb. Haemost. 86 (2001) 324-333
12. Marcy A.I., Eiberger L.L., Harrison R., Chan H.K., Hutchinson N.I., and Hagmann W.K. Human fibroblast stromelysin catalytic domain: expression, purification, and characterization of a C-terminally truncated form. Biochemistry 30 (1991) 6476-6483
13. 2+ dependent mechanism. Arch. Biochem. Biophys. 270 (1989) 478-488
14. + exchange via activation of the thrombin receptor. Biochem. J. 297 (1994) 47-52
15. 2 in human low-density lipoprotein. Biochim. Biophys. Acta 1583 (2002) 176-184
16. Pribluda V., and Rotman A. Dynamics of membrane-cytoskeleton interactions in activated blood platelets. Biochemistry 21 (1982) 2825-2832
17. Ray J.M., and Stetler-Stevenson W.G. The role of matrix metalloproteinases and their inhibitors in tumor invasion, metastasis and angiogenesis. Eur. Respir. J. 7 (1994) 2062-2072
18. Sawicki G., Salas E., Murat J., Miszta-Lane H., and Radomski M.W. Release of gelatinase A during platelet activation mediates aggregation. Nature 386 (1997) 616-618
19. Sheu J.R., Lin C.H., Peng C.H., and Huang T.F. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix protein via binding to multiple integrin receptors expressed on human hepatoma cells. Proc. Soc. Exp. Biol. Med. 213 (1996) 71-79
20. Sheu J.R., Lee C.R., Lin C.C., Kan Y.C., Lin C.H., Hung W.C., Lee Y.M., and Yen M.H. The antiplatelet activity of PMC, a potent α-tocopherol analogue, is mediated through inhibition of cyclooxygenase. Br. J. Pharmacol. 127 (1999) 1206-1212
21. Sheu J.R., Hung W.C., Wu C.H., Ma M.C., Kan Y.C., Lin C.H., Lin M.S., Luk H.N., and Yen M.H. Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia. Circulation 99 (1999) 3056-3062
22. Sheu J.R., Fong T.H., Liu C.M., Shen M.Y., Chen T.L., Chang Y., Lu M.S., and Hsiao G. Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies. Br. J. Pharmacol. 143 (2004) 193-201
23. 2+ concentrations in essential hypertension. Hypertension 22 (1993) 853-862
24. Wang G.R., Zhu Y., Halushka P.V., Lincoln T.M., and Mendelsohn M.E. Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 4888-4893
25. 2/NaOH/DMSO system. J. Agric. Food Chem. 47 (1999) 2544-2548